Recent Insider Transactions - Replimune (NASDAQ: REPL)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ REPL Replimune

Peeples-Dyer Veleka / director

04/01/2025

Buy

$8.40

32,000

$269K

32,000

NASDAQ REPL Replimune

Patel Sushil / director, officer: Chief Executive Officer

04/01/2025

Buy

$8.40

250,000

$2.100M

250,000

NASDAQ REPL Replimune

Pucci Paolo / director

04/01/2025

Buy

$8.40

32,000

$269K

32,000

NASDAQ REPL Replimune

Balachandran Madhavan / director

04/01/2025

Buy

$8.40

32,000

$269K

32,000

NASDAQ REPL Replimune

Xynos Konstantinos / officer: Chief Medical Officer

04/01/2025

Buy

$8.40

67,500

$567K

67,500

NASDAQ REPL Replimune

Dhingra Kapil / director

04/01/2025

Buy

$8.40

32,000

$269K

32,000

NASDAQ REPL Replimune

SLATTERY JOSEPH P / director

04/01/2025

Buy

$8.40

32,000

$269K

32,000

NASDAQ REPL Replimune

Hill Emily Luisa / officer: Chief Financial Officer

04/01/2025

Buy

$8.40

67,500

$567K

67,500

NASDAQ REPL Replimune

Weinand Dieter / director

04/01/2025

Buy

$8.40

32,000

$269K

32,000

NASDAQ REPL Replimune

Sarchi Christopher / officer: Chief Commercial Officer

04/01/2025

Buy

$8.40

67,500

$567K

67,500

NASDAQ REPL Replimune

Oliger Christy J. / director

04/01/2025

Buy

$8.40

32,000

$269K

32,000

NASDAQ REPL Replimune

Schwendenman Andrew / officer: Chief Accounting Officer

04/01/2025

Buy

$8.40

50,000

$420K

50,000

NASDAQ REPL Replimune

BAKER BROS. ADVISORS LP / director, 10 percent owner:

03/05/2025

Buy

$12.29

64,000

$787K

64,000